India grants emergency use authorization to Covaxin for 6-12 age group, Corbevax for 5-12 age group
STORY: India grants emergency use authorization to Covaxin for 6-12 age group, Corbevax for 5-12 age group
DATELINE: April 27, 2022
LENGTH: 00:01:32
LOCATION: New Delhi
CATEGORY: HEALTH
SHOTLIST:
1. STANDUP (English): DEEPAK PRAKASH, Xinhua reporter
2. various of street views of New Delhi
3. various of AIIMS (All India Institute Of Medical Science) hospital area
4. various of India's vaccination drive
STORYLINE:
STANDUP (English): DEEPAK PRAKASH, Xinhua reporter
"The Drugs Controller General of India (DCGI) Tuesday granted emergency use authorization to Covaxin for children between 6-12 years and Corbevax for those between 5-12 years of age."
The approval has come amid an uptick in the COVID-19 cases in schools. India is witnessing the surge in COVID-19 cases again at a time when markets have been reopened, businesses returned to normalcy and travel activities resumed to the pre-pandemic levels. Schools and colleges have been open for in-person classes and there is no bar to gatherings.
The approval by t
- Product Code
- ILEA000959103
- Registered date
- 2022/4/27 00:00:00
- Credit
- Xinhua / Kyodo News Images
- Media source
- Xinhua News Agency.All Rights Reserved
- Media size
- 1920 × 1080 pixel
- Deployment size
- 92.50(MB)*
*File size when opened in Photoshop, etc.